←
Isabelle Opitz389 posts
Isabelle Opitz avatar✓

Isabelle Opitz ✓

@IsaOpitz

Director Thoracic Surgery @ThoracicZurich @Unispital_USZ Professor of Thoracic Surgery @UZH

◷ Joined February 2015▧ 78 Photos and videos
Isabelle Opitz avatar
Isabelle Opitz@IsaOpitz·Nov 2

🌍 @myESMO 2026 | Madrid, Spain Inspiring days at #ESMO2026, with exciting developments for the #LungCancer community! 🔬 1/5 🧬 Major attention was drawn to DeLLphi-305, bringing promising news for patients with SCLC, alongside SAFFRON and OptiTROP-Lung06. 2/5 📊 The SARON trial showed improved progression-free survival in driver-negative oligometastatic NSCLC with radiotherapy (13.9 vs. 8.9 months), although no overall survival benefit was observed. Important findings presented by @fifimcdrmh 3/5 🔪 Exciting developments for the surgical community! CTONG 1804 reported #conversion rates approaching 50%. @DoctorJSpicer presented findings from MDT-BRIDGE, highlighting the potential of ctDNA clearance as a predictor of pathological complete response (pCR) in resectable and borderline resectable NSCLC. ctDNA clearance at C2D1 showed an 83.3% positive predictive value for pCR, providing valuable insights into treatment response. 4/5 🧬 De-escalation of immunotherapy in advanced or metastatic cancer was another key topic. While reducing treatment intensity may improve quality of life and minimise toxicity, further evidence is needed before routine implementation. 5/5 🎤 Delighted to contribute to the early-stage track alongside @MarianaBrandao0 , @stephanieplsaw , Jan von der Thüsen and Suresh Senan, discussing: “Multistation N2 (N2b), T4 lesions, and pneumonectomy: Time to reconsider induction chemo-immunotherapy?” A valuable congress filled with scientific exchange, innovation and new perspectives for thoracic oncology! #ESMO #ThoracicSurgery #LungCancer #Oncology #Immunotherapy #ClinicalTrials #USZ

Post attachmentPost attachment
ESTS avatar
⟳ Isabelle Opitz retweeted
ESTS@thoracic·Oct 26

Advance your ECMO skills with ESTS! Join the Basic Adult ECMO Course & Simulation Training for thoracic surgeons in Zurich, 17–18 Dec 2026. Explore hands-on training in ECMO management and cannulation. Register: emma.events/ESTS-ECMO2026 #ESTS #ECMO

Post attachment
ESTS avatar
⟳ Isabelle Opitz retweeted
ESTS@thoracic·Oct 21

🎙️ Follow ESTS so you don't miss the launch! Meet the first guests of THE SHARP END: our brand-new podcast: 1️⃣ Isabelle Opitz 2️⃣ Anne-Marie Dingemans 3️⃣ Robert Cerfolio Candid conversations at the cutting edge of thoracic surgery. Coming soon 🫁 #TheSharpEnd #ESTS #Podcast

Post attachment
ESTS avatar
⟳ Isabelle Opitz retweeted
ESTS@thoracic·Sep 29

Zurich awaits. ⛰️ Zurich offers a striking backdrop for ESTS 2027- combining a distinctive city atmosphere with excellent international accessibility. Start planning your journey: 👉 estsmeeting.com/getting-to-z… 📆 30 May - 1 June 📍 Zurich #ThoracicSurgery

Post attachment
Isabelle Opitz avatar
Isabelle Opitz@IsaOpitz·Sep 18

🏆IASLC Cancer Care Team Award Europe🏆 What a special moment at the @IASLC #WCLC2026 in Seoul! I am incredibly proud that our multidisciplinary team has been honoured with the @IASLC Cancer Care Team Award for Europe. This recognition reflects what truly defines modern cancer care: close collaboration across disciplines and professions, combining different perspectives and expertise with one common goal - providing the best possible care for our patients. I am very grateful to share this recognition with an outstanding team: @HillingerSven , Annegret Hinkelmann, Albana Rexhepaj, @raph_werner, @jonas_willmann, Laura Boos, Gian-Marco Monsch, @OliviaLauk, @SilviaUlrich6, Carolin Steinack, Andreas Wicki, Caroline Hertler, @UszDidi, Ömer Senbaklavaci, @Mat_Guc This award belongs to the entire team and represents the dedication, trust and interdisciplinary collaboration that make comprehensive cancer care possible every day. I am deeply grateful for this recognition and very proud of what we have achieved together. #WCLC2026 #IASLC #CancerCareTeamAwardEurope #LungCancer #ThoracicOncology #MultidisciplinaryCare #Teamwork #ThoracicSurgery

Post attachmentPost attachmentPost attachment
Stephen V Liu, MD avatar
⟳ Isabelle Opitz retweeted
Stephen V Liu, MD@StephenVLiu·Sep 13

8 year update of ADAURA at #WCLC26 from @DrRoyHerbst - with 3y of adjuvant osimertinib in EGFR mutant NSCLC, 8y OS rate 74% vs 58% with OS HR 0.53 and benefit seen across stages: stage IB HR 0.50, stage II HR 0.60, stage IIIA HR 0.49 - reaffirms standard of care.

Post attachmentPost attachmentPost attachmentPost attachment
Stephen V Liu, MD avatar
⟳ Isabelle Opitz retweeted
Stephen V Liu, MD@StephenVLiu·Sep 13

Congratulations to Dr. @pompili_cecilia - the #WCLC26 winner of the Robert J. Ginsburg Lectureship Award for Surgery. Pioneering work on patient reported outcomes, focusing the field and innovation on what is best for each patient. A true leader who always leads with kindness.

Post attachmentPost attachmentPost attachment
Isabelle Opitz avatar
Isabelle Opitz@IsaOpitz·Sep 4

💙 Behind Every Successful Operation Is an Exceptional Team Every successful operation relies on dedicated professionals working together to provide the best possible care for our patients. Today, we would like to recognise our Operating Department Practitioners and especially thank Felix Jose Vega, Pili Vega and Bashkim Maksuti for their expertise, reliability and commitment to our team. As Felix and Pili begin their well-deserved retirement, we would like to thank them for their many years of dedication and the important contribution they have made to @ThoracicZurich at the @Unispital_USZ . Your experience, support and positive spirit will certainly be missed. And to Bashkim Maksuti: thank you for your continued dedication and for being such a valued part of our team. Felix and Pili, we wish you all the very best for this new chapter, and above all, plenty of time to enjoy it! 💙 #ThoracicSurgery #OperatingRoom #Teamwork #PatientCare #Retirement #UniversityHospitalZurich #OperatingDepartmentPractitioner

Post attachmentPost attachment
Isabelle Opitz avatar
Isabelle Opitz@IsaOpitz·Aug 18

🫁 New AATS Expert Consensus Document on N2+ NSCLC It was a pleasure and great learning to contribute to the 2026 @AATSHQ Expert Consensus Document on the evaluation and management of N2+ non-small cell lung cancer (NSCLC) under the leadership of Philip Linden and Thomas D'Amico. The management of N2-positive NSCLC remains one of the most complex areas in thoracic oncology! This new consensus document provides updated recommendations on staging, patient selection and treatment strategies, highlighting the importance of multidisciplinary decision-making and close collaboration across specialties. 🤝🫁 Many thanks to the @AATSHQ and all colleagues involved in this collaborative effort. Link to the paper: hubs.la/Q04rRCG50 #ThoracicSurgery #LungCancer #NSCLC #SurgicalOncology #MultimodalTherapy #AATS

Post attachment
ESTS avatar
⟳ Isabelle Opitz retweeted
ESTS@thoracic·Aug 11

🫁 VITOS 2026 is coming to Vienna! Join leading experts for 2 days of cutting-edge thoracic oncology science. Endorsed by @ESTS_thoracic. 📍20–21 Nov 2026 🌐 In-person + live stream 💶 Free (registration required) 👉 Register: ests.org/events/279/vienna_i…

Post attachment
IASLC avatar
⟳ Isabelle Opitz retweeted
IASLC@IASLC·Aug 1

Lung cancer care is changing what is possible for patients. IASLC Board Member @IsaOpitz shares her perspective on the progress transforming detection, treatment, and care. Watch her World Lung Cancer Day message. #WorldLungCancerDay #ConquerLungCancer

1:58